Free Trial
NASDAQ:GELS

Gelteq (GELS) Stock Price, News & Analysis

Gelteq logo
$1.68 +0.01 (+0.60%)
As of 04:00 PM Eastern

About Gelteq Stock (NASDAQ:GELS)

Key Stats

Today's Range
$1.60
$1.79
50-Day Range
$0.82
$2.88
52-Week Range
$0.77
$5.50
Volume
53,576 shs
Average Volume
1.06 million shs
Market Capitalization
$15.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gelteq Inc. is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc. is based in NEW YORK.

Receive GELS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter.

GELS Stock News Headlines

Gelteq Limited Ordinary Shares (GELS)
Shocking discovery could help you target payouts on weekends…
Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...
See More Headlines

GELS Stock Analysis - Frequently Asked Questions

Gelteq's stock was trading at $2.32 at the start of the year. Since then, GELS stock has decreased by 27.6% and is now trading at $1.68.
View the best growth stocks for 2025 here
.

Gelteq (GELS) raised $5 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 1,300,000 shares at $4.00 per share. The Benchmark Company acted as the underwriter for the IPO.

Gelteq's lock-up period expired on Monday, April 28th. Gelteq had issued 1,300,000 shares in its public offering on October 29th. The total size of the offering was $5,200,000 based on an initial share price of $4.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

Shares of GELS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GELS
Previous Symbol
NASDAQ:GELS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$15.86 million
Optionable
N/A
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:GELS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners